Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia.

Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q53210874

Q53210874

about

How old is old: the beginning of a new era for therapeutic challenges for elderly patients with AML.Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status.

P2860

Q42119105-0C77DC46-F58D-4DF8-BF71-29F48477D79C Q46211544-CDBEB866-57BA-4E7C-93C3-9452210A4DD4

P2860

Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q53210874

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Hematopoietic stem cell transp ...... s with acute myeloid leukemia.

@en

Hematopoietic stem cell transp ...... s with acute myeloid leukemia.

@nl

type

Item

label

Hematopoietic stem cell transp ...... s with acute myeloid leukemia.

@en

Hematopoietic stem cell transp ...... s with acute myeloid leukemia.

@nl

prefLabel

Hematopoietic stem cell transp ...... s with acute myeloid leukemia.

@en

Hematopoietic stem cell transp ...... s with acute myeloid leukemia.

@nl

P1476

Hematopoietic stem cell transp ...... s with acute myeloid leukemia.

@en

P2093

Byung-Sik Cho

http://www.w3.org/2001/XMLSchema#string

Chang-Ki Min

http://www.w3.org/2001/XMLSchema#string

Chong-Won Park

http://www.w3.org/2001/XMLSchema#string

Dong-Gun Lee

http://www.w3.org/2001/XMLSchema#string

Dong-Wook Kim

http://www.w3.org/2001/XMLSchema#string

Hee-Je Kim

http://www.w3.org/2001/XMLSchema#string

Jong-Wook Lee

http://www.w3.org/2001/XMLSchema#string

Ki-Seong Eom

http://www.w3.org/2001/XMLSchema#string

Seok Lee

http://www.w3.org/2001/XMLSchema#string

Seok-Goo Cho

http://www.w3.org/2001/XMLSchema#string

P2860

CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.

Age and acute myeloid leukemia.

HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia.

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

CD 33 as a target of therapy in acute myeloid leukemia: current status and future perspectives.

Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor

Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of patients > or =60 years with acute myelogenous leukemia.

P304

2321-2328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2011.587562

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Su-Mi Choi

P577

2011-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22023488

http://www.w3.org/2001/XMLSchema#string

Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia.

about

P2860

P2860

Hematopoietic stem cell transplant following remission induction chemotherapy including gemtuzumab ozogamicin is a feasible and effective treatment option in elderly patients with acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698